Pages that link to "Q36998127"
Jump to navigation
Jump to search
The following pages link to Early cardiac function monitoring for detection of subclinical Doxorubicin cardiotoxicity in young adult patients with breast cancer (Q36998127):
Displaying 9 items.
- Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity (Q26744675) (← links)
- Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study. (Q33752979) (← links)
- Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer (Q37547962) (← links)
- No Acute Changes in LVEF Observed With Concurrent Trastuzumab and Breast Radiation With Low Heart Doses. (Q46221563) (← links)
- Can we predict clinical cardiotoxicity with cardiac biomarkers in patients after haematopoietic stem cell transplantation? (Q48495062) (← links)
- Patient preference and timing for exercise in breast cancer care (Q50495928) (← links)
- Oncological safety of nipple-sparing mastectomy in young patients with breast cancer compared with conventional mastectomy. (Q52355152) (← links)
- Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography. (Q53075042) (← links)
- The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cells. (Q55385181) (← links)